CCN2 and Hyperglycemia: In conclusion, our results suggested that MDG-1 has a renoprotective effect via reduction of hyperglycemia, which attenuates the concentration of serum albumin and down-regulates the expression of TGF-β1 and CTGF in diabetic glomeruli, consequently decreasing ECM deposition in renal tissues.